Illumina, Inc. announced its participation in Time Boost Capital I LP, a £30 million genomics venture fund dedicated to providing match funding to startups graduating from Illumina Accelerator with the aim to advance breakthroughs in human health.
Predominantly Black and Hispanic lower-income communities are experiencing some of the most devastating impacts of the pandemic. Upon the launch of Q4HE, these vulnerable communities were the first priority.
Q4HE provided Cedarbrook with COVID-19 PCR testing for 600 staff members and 500 residents at their facility, with twice-weekly collections over a 12-week period—offering much-needed support to some of the most vulnerable members of the population.
As Kimberly-Clark celebrates 150 years of providing Better Care for a Better World, the Kimberly-Clark Foundation announced that it will honor this milestone anniversary by awarding three $150,000 grants to global nonprofit organizations.
This March, Australia launched the Precision Oncology Screening Platform Enabling Clinical Trials (PrOSPeCT), which will sequence the genomes of more than 20,000 cancer patients, many with rare and challenging tumors.
“Cancer is a frightening diagnosis,” said Louis J. DeGennaro, Ph.D., who worked for decades in cancer drug discovery and now serves as president and CEO of the Leukemia & Lymphoma Society (LLS).
Green Shield Canada (GSC) is proud to release its 2021 Social Impact Report, tracking organizational highlights from the past year and documenting GSC’s commitment to Better Health for All.
The SCS Kingfisher certification mark is showing up on an increasing number of products around the world. It differentiates companies that are making...
Corporate governance, risk management, operational integrity, and regulatory compliance are demanding challenges that companies face in today’s ever...
Cascale shares updates on its strategic partnerships with industry stakeholders geared toward shifting the industry into one that gives back more than...
